Financial Statements
P&L · Balance Sheet · Cash Flow · IFRS-compliant · Multi-period · Period-end close
Profit & Loss — YTD as of June 2026
REVENUE
Patient Services Revenue108,000,000budget 100,000,0008.0%
Pharmacy Sales18,400,000budget 18,000,0002.2%
Laboratory Services8,200,000budget 7,500,0009.3%
Imaging Services7,400,000budget 7,000,0005.7%
Other Income1,200,000budget 1,000,00020.0%
Total REVENUE143,200,000133,500,000
DIRECT COSTS
Medical Supplies & Drugs-42,000,000budget -40,000,0005.0%
Clinical Salaries-32,000,000budget -31,000,0003.2%
Lab & Imaging Consumables-8,400,000budget -8,000,0005.0%
Total DIRECT COSTS-82,400,000-79,000,000
OPERATING EXPENSES
Administrative Salaries-12,000,000budget -12,000,0000.0%
Facility & Utilities-8,400,000budget -8,200,0002.4%
IT & Software-3,200,000budget -3,000,0006.7%
Marketing & Sales-1,800,000budget -2,000,000-10.0%
Insurance & Compliance-2,400,000budget -2,400,0000.0%
Depreciation & Amortization-4,800,000budget -4,800,0000.0%
Total OPERATING EXPENSES-32,600,000-32,400,000
NET INCOME28,200,00022,100,000